Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.

1. The radioligand binding characteristics of the 3H-derivative of the novel 5-HT3 receptor antagonist BRL46470 were investigated and directly compared to the well characterized 5-HT3 receptor radioligand [3H]-granisetron, in tissue homogenates prepared from rat cerebral cortex/hippocampus, rat ileu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Steward, L. J., Ge, J., Bentley, K. R., Barber, P. C., Hope, A. G., Lambert, J. J., Peters, J. A., Blackburn, T. P., Barnes, N. M.
Format: Artigo
Jezik:Inglês
Izdano: 1995
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1909107/
https://ncbi.nlm.nih.gov/pubmed/8528560
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items